What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?
A
Andrew Badrot
A
Anthony Fitzpatrick
S
Sean Kirk
J
Jean Bléhaut
B
Ben Zeskind, Ph.D.
Over the past three decades, the pharmaceutical supply chain has grown more complex and international to meet policies focused on aggressively decreasing drug prices.
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications, Particularly in Resource-Limited Settings?
S
Spandan Mishra
J
Justin Kong
C
Carol Houts
P
Priya Baraniak, Ph.D.
A
Andre Unglert
Biopharma companies play a major role in improving global access to essential medications by introducing low-cost versions of off-patent, high-value biological drugs, commonly known as 'biosimilars.'
